DrPaul Bentley
Senior Clinical Research Fellow
Department of Brain Sciences - Faculty of Medicine
Orcid identifier0000-0001-8036-7010 (opens in a new tab)
- Senior Clinical Research FellowDepartment of Brain Sciences - Faculty of Medicine
- 10L21, Charing Cross Hospital, Charing Cross Campus, United Kingdom
BIO
Paul Bentley is Clinical Director of the Imperial College Network Of Excellence in Rehabilitation Technology; Senior Lecturer; and Consultant Neurologist within Brain Sciences, Imperial College London. After training at Cambridge and UCL, he undertook a research fellowship in Psychology Dept, Harvard, and a PhD in Cognitive Neuroscience at UCL. He is the first UK neurologist to have been dually-accredited in stroke medicine by the Royal College of Physicians. Awards include: UK Government National Clinical Impact Award; UK Stroke Association Fellowship; Dept. of Health 'New Blood' Lectureship Award; NHS England Innovation Prize; UK Stroke Forum Prize; Association of British Neurologists Prize. He leads a NIHR-funded project developing the world's first "social network" of online interactive rehabilitation; and is the Clinical Founder of a university spinout for exercise-gaming physiotherapy (Gripable).
Research
In case you havent noticed, Healthcare (and everything else in society) is in the grips of a Technological Revolution. Our group apply latest advances in wearables, sensors, smart-devices, robotics and AI, towards improving diagnosis, prediction, monitoring, treatment and cost-efficiency. We work closely with world experts in Bioengineering and Data Science, to ensure that technical innovation is focused towards the most pressing clinical challenges. Particular interests are neuroimaging, behavioural monitoring, and physical exercise.
Notable achievements include:
1. Inventing a low-cost, portable gaming device enabling disabled people who need physiotherapy to exercise at home. The device increases exercise intensity in a broad range of patient types, without requiring extra professional supervision. The device is now used by >350 centres worldwide and >8000 patients (See: The Sun Article; The Mirror Feature; BBC News Feature. (In collaboration with Human Robotics Group, Imperial College).
2. Developing automated imaging analytic algorithms that quantify stroke and dementia severity using the most widely used type of brain scan (CT). The method is used by international registries of stroke treatment e.g. HERMES. Acknowledged in: Lancet Editorial - Research Highlights 2018 (ref. #1); Chief Medical Officer, UK Government, Annual Report (pp.205, ref#21). (In collaboration with Medical Imaging Analysis Group, Imperial College).
3. World-first trial of immunoselected CD34 stem cells in stoke, delivered directly to the brain. See: Telegraph Article; Guardian Article; Washington Post.
4. Demonstrating that paralysis after stroke is caused by damage not just to "movement" parts of the brain (i.e. motor) but also the "thinking" parts of the brain (i.e. executive) (see PNAS article).
Research
In case you havent noticed, Healthcare (and everything else in society) is in the grips of a Technological Revolution. Our group apply latest advances in wearables, sensors, smart-devices, robotics and AI, towards improving diagnosis, prediction, monitoring, treatment and cost-efficiency. We work closely with world experts in Bioengineering and Data Science, to ensure that technical innovation is focused towards the most pressing clinical challenges. Particular interests are neuroimaging, behavioural monitoring, and physical exercise.
Notable achievements include:
1. Inventing a low-cost, portable gaming device enabling disabled people who need physiotherapy to exercise at home. The device increases exercise intensity in a broad range of patient types, without requiring extra professional supervision. The device is now used by >350 centres worldwide and >8000 patients (See: The Sun Article; The Mirror Feature; BBC News Feature. (In collaboration with Human Robotics Group, Imperial College).
2. Developing automated imaging analytic algorithms that quantify stroke and dementia severity using the most widely used type of brain scan (CT). The method is used by international registries of stroke treatment e.g. HERMES. Acknowledged in: Lancet Editorial - Research Highlights 2018 (ref. #1); Chief Medical Officer, UK Government, Annual Report (pp.205, ref#21). (In collaboration with Medical Imaging Analysis Group, Imperial College).
3. World-first trial of immunoselected CD34 stem cells in stoke, delivered directly to the brain. See: Telegraph Article; Guardian Article; Washington Post.
4. Demonstrating that paralysis after stroke is caused by damage not just to "movement" parts of the brain (i.e. motor) but also the "thinking" parts of the brain (i.e. executive) (see PNAS article).
FACULTY
- Faculty of Medicine
POSITION NAME
- Senior Clinical Research Fellow